BNP Paribas Financial Markets’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

BNP Paribas Financial Markets’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$56.2K	Sell	28,836 -44,266	-61%	-$90.3K	﹤0.01%	4830
2026 Q1	$180K	Sell	73,102 -43,603	-37%	-$146K	﹤0.01%	4096
2025 Q4	$464K	Sell	116,705 -2,807	-2%	-$12.4K	﹤0.01%	3610
2025 Q3	$452K	Sell	119,512 -2,893	-2%	-$9.82K	﹤0.01%	3590
2025 Q2	$296K	Buy	122,405 +1,496	+1%	+$2.03K	﹤0.01%	3611
2025 Q1	$99.6K	Buy	120,909 +11,700	+11%	+$11.1K	﹤0.01%	4039
2024 Q4	$92.8K	Buy	+109,209	New	+$122K	﹤0.01%	4179
2022 Q4	–	Sell	-32,756	Closed	-$131K	–	4308
2022 Q3	$131K	Buy	+32,756	New	+$248K	﹤0.01%	3666

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets's NBP Position: Q2 2026 in Review

BNP Paribas Financial Markets reduced its NovaBridge Biosciences American Depositary Shares (NBP) stake by 61% in Q2 2026, selling an estimated $90.3K and leaving 28,836 shares worth $56.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4830.

BNP Paribas Financial Markets first reported a position in NBP in Q3 2022 and has held it in 8 quarters since. The position peaked at $464K in Q4 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

BNP Paribas Financial Markets held 28,836 shares of NovaBridge Biosciences American Depositary Shares worth $56.2K as of Q2 2026.
BNP Paribas Financial Markets sold 44,266 NovaBridge Biosciences American Depositary Shares shares in Q2 2026, an estimated $90.3K.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4830 holding.
BNP Paribas Financial Markets first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2022 and has held it in 8 quarters since.
BNP Paribas Financial Markets's NovaBridge Biosciences American Depositary Shares position peaked at $464K in Q4 2025.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.